Showing results (171-180 of 496) with videos related to
Sort By:
Pageof 50
Advances in Neurology|January 1, 1987
Terguride: partial dopamine agonist in the treatment of Parkinson's diseaseT Brücke, W Danielczyk, M Simányi, et al.European Journal of Pharmacology|June 13, 1996
Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridiniumE Koutsilieri, T S Chen, W D Rausch, et al.Pharmacopsychiatry|May 1, 1990
Brofaromine (CGP 11 305 A) in treatment of depression: biological estimation of plasma concentrationsJ Fritze, T Becker, V Ziegler, et al.Handbook of Clinical Neurology|March 3, 2018
Neurochemical markers as potential indicators of postmortem tissue qualityJ Sian-Hülsmann, C-M Monoranu, E Grünblatt, et al.Journal of Neural Transmission. Supplementum|February 24, 2001
Impaired iron homeostasis in Parkinson's diseaseK L Double, M Gerlach, M B Youdim, et al.Journal of Neural Transmission. Supplementum|January 1, 1983
General properties of 14C-L-Valine-binding to human brain tissueP Riederer, E Kienzl, K Jellinger, et al.Journal of Neural Transmission|January 1, 1987
Reduced concentrations and increased metabolism of biogenic amines in a single case of Rett-syndrome: a postmortem brain studyT Brücke, E Sofic, W Killian, et al.Annals of Neurology|September 28, 1998
Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress?G Münch, M Gerlach, J Sian, et al.Journal of Neurovirology|December 20, 2002
Psychiatric complications in human immunodeficiency virus infectionE Koutsilieri, C Scheller, S Sopper, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
Methylmercury induces neurite degeneration in primary culture of mouse dopaminergic mesencephalic cellsM E Götz, E Koutsilieri, P Riederer, et al.Pageof 50